A detailed history of Cibc Private Wealth Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,996 shares of EXAS stock, worth $261,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,996
Previous 4,070 1.82%
Holding current value
$261,897
Previous $281,000 40.21%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$41.33 - $74.26 $3,058 - $5,495
-74 Reduced 1.82%
3,996 $168,000
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $6,752 - $8,852
120 Added 3.04%
4,070 $281,000
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $233,287 - $299,094
3,950 New
3,950 $292,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $258,550 - $388,335
3,921 New
3,921 $267,000
Q2 2023

Nov 21, 2023

BUY
$62.68 - $95.05 $139,588 - $211,676
2,227 New
2,227 $209,000
Q2 2023

Aug 10, 2023

BUY
$62.68 - $95.05 $139,588 - $211,676
2,227 New
2,227 $209,000
Q2 2022

Aug 03, 2022

SELL
$35.61 - $76.23 $230,895 - $494,275
-6,484 Reduced 99.54%
30 $1,000
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $14,447 - $20,717
-251 Reduced 3.71%
6,514 $455,000
Q4 2021

Feb 08, 2022

SELL
$72.5 - $100.68 $17.7 Million - $24.6 Million
-244,804 Reduced 97.31%
6,765 $527,000
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $3.4 Million - $4.68 Million
37,700 Added 17.63%
251,569 $24 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $465,396 - $692,032
-4,969 Reduced 2.27%
213,869 $26.6 Million
Q1 2021

May 12, 2021

SELL
$116.57 - $155.01 $1.02 Million - $1.35 Million
-8,718 Reduced 3.83%
218,838 $28.8 Million
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $430,713 - $614,526
-4,324 Reduced 1.86%
227,556 $30.1 Million
Q3 2020

Nov 03, 2020

BUY
$72.92 - $102.01 $16.9 Million - $23.7 Million
231,880 New
231,880 $23.6 Million
Q3 2020

Oct 29, 2020

SELL
$72.92 - $102.01 $16.7 Million - $23.3 Million
-228,433 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $637,445 - $1.06 Million
-11,434 Reduced 4.77%
228,433 $19.9 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $267,990 - $738,495
-7,071 Reduced 2.86%
239,867 $13.9 Million
Q4 2019

Jan 30, 2020

SELL
$77.66 - $99.74 $701,813 - $901,350
-9,037 Reduced 3.53%
246,938 $22.8 Million
Q3 2019

Oct 16, 2019

SELL
$90.37 - $122.49 $68.3 Million - $92.5 Million
-755,246 Reduced 74.69%
255,975 $23.1 Million
Q2 2019

Jul 31, 2019

SELL
$89.51 - $118.04 $3.42 Million - $4.51 Million
-38,241 Reduced 3.64%
1,011,221 $119 Million
Q1 2019

May 10, 2019

BUY
$61.98 - $96.5 $8.73 Million - $13.6 Million
140,825 Added 15.5%
1,049,462 $90.9 Million
Q4 2018

Feb 05, 2019

SELL
$56.04 - $82.66 $10.7 Million - $15.8 Million
-190,930 Reduced 17.36%
908,637 $57.3 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $365,507 - $610,061
-7,569 Reduced 0.68%
1,099,567 $86.8 Million
Q2 2018

Aug 02, 2018

BUY
$37.84 - $69.96 $18.2 Million - $33.7 Million
481,230 Added 76.89%
1,107,136 $66.2 Million
Q1 2018

May 17, 2018

BUY
$39.82 - $57.53 $20.2 Million - $29.1 Million
506,404 Added 423.76%
625,906 $25.2 Million
Q4 2017

Feb 12, 2018

BUY
$46.49 - $60.51 $5.56 Million - $7.23 Million
119,502
119,502 $6.28 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.6B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.